search
Back to results

Comparison of Subjective Refraction Measurement With SiVIEW Software and by an Expert

Primary Purpose

Eye Diseases, Ametropia

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
SiVIEW software
Expert
Sponsored by
SiVIEW
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Eye Diseases focused on measuring automatic sphere measurements, eye examination, ametropia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • subject with visual AV on each eye >= 8/10 and no amblyopia
  • subject with normal environmental transparency
  • subject with a healthy fundus that does not reveal major abnormalities that may affect vision
  • subject able to read the letters of the Latin alphabet
  • subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
  • non-diabetic subject
  • non nystagmic subject
  • non-strabic subject
  • subject who has not had eye surgery less than 1 year old

Exclusion Criteria:

  • subject with a topography showing an anomaly (keratoconus type or other)

Sites / Locations

  • Ophthalmological Foundation A. de Rothschild

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Eye examination by expert and SiVIEW software

Arm Description

Eye examination by an expert and by a technician with the SiVIEW system.

Outcomes

Primary Outcome Measures

Equivalent sphere measurement
The subject will have an eye exam with SiVIEW and an examination by an optometrist expert. The equivalent sphere value will be evaluated in both cases.

Secondary Outcome Measures

Sphere measurement
The subject will have an eye exam performed with SiVIEW and by an optometrist expert. The sphere value will be evaluated in both cases. The examination will be started in both cases on the objective measurement value obtained during the routine care examination.
Cylinder measurement
The subject will have an eye exam performed with SiVIEW and by an optometrist expert. The cylinder value will be evaluated in both cases. The examination will be started in both cases on the objective measurement value obtained during the routine care examination.
Visual acuity
The subject will have an eye exam performed with SiVIEW and by an optometrist expert. The value of visual acuity will be assessed in both cases.
Consistency and relevance of the SiVIEW report
After each examination, the report edited by the SiVIEW software will be scored consistently on a Likert scale from 1 to 5 by an expert optometrist: 1: very inconsistent / 2: inconsistent / 3: no opinion / 4: consistent / 5: very consistent After each examination, the report edited by SiVIEW software will be scored in relevance on a 5 item Likert scale by an expert optometrist: 1: not relevant / not very relevant / no opinion / relevant / very relevant.
Measurement between two optometrist experts
Each subject will have an eye examination conducted with an optometrist from the current care centre and by an optometrist expert mandated by SiVIEW (who is used to working at the Rothschild Foundation in clinical studies, among others). The equivalent sphere value will be evaluated in both cases.

Full Information

First Posted
November 30, 2019
Last Updated
May 4, 2022
Sponsor
SiVIEW
search

1. Study Identification

Unique Protocol Identification Number
NCT04185701
Brief Title
Comparison of Subjective Refraction Measurement With SiVIEW Software and by an Expert
Official Title
Study of the Subjective Refraction Measured With SiVIEW Software Compared to That Obtained Manually by an Expert. Monocentric Cross-sectional Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 2022 (Anticipated)
Primary Completion Date
February 2023 (Anticipated)
Study Completion Date
April 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
SiVIEW

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Main objective Show that the equivalent sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Secondary objectives Show that the sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Show that the cylinder refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Show that the visual acuity measurements obtained by the SiVIEW software do not have a significant clinical difference with those obtained by an optometrist expert. Demonstrate that the report delivered for each eye exam by SiVIEW software is consistent and relevant to a vision health practitioner. Show that the differences obtained between two eye examination experts are consistent with those found in the literature.
Detailed Description
Introduction: Ametropia is an eye refractive disorder typically leading to myopia, hyperopia, astigmatism... 4.5 billion people are currently affected worldwide, of whom only 2 billion are corrected. Of these people, about 30% (or +/- 600,000) do not benefit from an adequate correction. From an economic point of view, the cost on productivity of the absence or poor vision correction is estimated at more than 270 billion euros / year worldwide. Any correction of an ametropic disorder necessarily requires a precise and relevant eye examination in order to identify the disorder and determine the best possible visual correction. The procedure for this examination is identical in all countries. It must follow specific steps[Benjamin 2006; Grosvenor 2007]. At present the refraction measurement is done manually by an expert. The optical correction may vary from one examination to another, for multiple physiological and/or examination-related reasons. Several factors can cause fluctuations in subjective refraction. These include examiner and subject characteristics [Grein et al. 2014]. In addition, there is also variability due to the measurement itself, depending on each examiner. The repeatability (on the same subject) and, in addition, the reproducibility (inter-examiners) of the subjective refraction measurement related to the examiner's interpretation, examination process and experience, among other things, are therefore important data to be defined in order to know the tolerance of the measurement determined between two examinations. In studies involving a large number of subjects, the repeatability/reproducibility limit is greater than or equal to 0.71D [Zadnik 1994, Bullimore 1998, MacKenzie 2008], and more particularly during inter-examiner measurements. The objective of the SiVIEW solution is therefore to make the measurement of subjective refraction both repeatable and reproducible regardless of the practitioner and his expertise, by completely automating the search for the best visual prescription using an expert system that aims to make this examination simple, intuitive and reliable. It is therefore essential to compare the SiVIEW measurement with that of an optometrist expert. The interest of the investigator's study will be to demonstrate that the results between a refraction expert and the measurement obtained by SiVIEW are clinically similar. Main objective: Show that the equivalent sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Secondary objectives Show that the sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Show that the cylinder refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Show that the visual acuity measurements obtained by the SiVIEW software do not have a significant clinical difference with those obtained by an optometrist expert. Demonstrate that the report delivered for each eye exam by SiVIEW software is consistent and relevant to a vision health practitioner. Show that the differences obtained between two eye examination experts are consistent with those found in the literature. Plan of the study: It is a comparative prospective open monocentric cross-sectionnal study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Eye Diseases, Ametropia
Keywords
automatic sphere measurements, eye examination, ametropia

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
Eye examination by an expert including optimal correction in distance and near vision Eye examination by a technician with the SiVIEW system Analysis of the SiVIEW report by the expert who conducted the second review
Masking
None (Open Label)
Allocation
N/A
Enrollment
111 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Eye examination by expert and SiVIEW software
Arm Type
Experimental
Arm Description
Eye examination by an expert and by a technician with the SiVIEW system.
Intervention Type
Other
Intervention Name(s)
SiVIEW software
Intervention Description
Eye examination by a technician with the SiVIEW software
Intervention Type
Other
Intervention Name(s)
Expert
Intervention Description
Eye examination by an expert including optimal correction in distance and near vision
Primary Outcome Measure Information:
Title
Equivalent sphere measurement
Description
The subject will have an eye exam with SiVIEW and an examination by an optometrist expert. The equivalent sphere value will be evaluated in both cases.
Time Frame
At time of inclusion
Secondary Outcome Measure Information:
Title
Sphere measurement
Description
The subject will have an eye exam performed with SiVIEW and by an optometrist expert. The sphere value will be evaluated in both cases. The examination will be started in both cases on the objective measurement value obtained during the routine care examination.
Time Frame
At time of inclusion
Title
Cylinder measurement
Description
The subject will have an eye exam performed with SiVIEW and by an optometrist expert. The cylinder value will be evaluated in both cases. The examination will be started in both cases on the objective measurement value obtained during the routine care examination.
Time Frame
At time of inclusion
Title
Visual acuity
Description
The subject will have an eye exam performed with SiVIEW and by an optometrist expert. The value of visual acuity will be assessed in both cases.
Time Frame
At time of inclusion
Title
Consistency and relevance of the SiVIEW report
Description
After each examination, the report edited by the SiVIEW software will be scored consistently on a Likert scale from 1 to 5 by an expert optometrist: 1: very inconsistent / 2: inconsistent / 3: no opinion / 4: consistent / 5: very consistent After each examination, the report edited by SiVIEW software will be scored in relevance on a 5 item Likert scale by an expert optometrist: 1: not relevant / not very relevant / no opinion / relevant / very relevant.
Time Frame
At time of inclusion
Title
Measurement between two optometrist experts
Description
Each subject will have an eye examination conducted with an optometrist from the current care centre and by an optometrist expert mandated by SiVIEW (who is used to working at the Rothschild Foundation in clinical studies, among others). The equivalent sphere value will be evaluated in both cases.
Time Frame
At time of inclusion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: subject with visual AV on each eye >= 8/10 and no amblyopia subject with normal environmental transparency subject with a healthy fundus that does not reveal major abnormalities that may affect vision subject able to read the letters of the Latin alphabet subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids non-diabetic subject non nystagmic subject non-strabic subject subject who has not had eye surgery less than 1 year old Exclusion Criteria: subject with a topography showing an anomaly (keratoconus type or other)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laure Pichereau
Phone
(+33) 638949740
Email
laure@siview.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Damien Gatinel, MD
Organizational Affiliation
Head of Department Ophthalmological Foundation A. de Rothschild, Paris, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ophthalmological Foundation A. de Rothschild
City
Paris
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Damien Gatinel, MD
Phone
(+33)148036482
Email
ebarbosa@for.paris

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Comparison of Subjective Refraction Measurement With SiVIEW Software and by an Expert

We'll reach out to this number within 24 hrs